These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Oligomerization of the soluble granulocyte-macrophage colony-stimulating factor receptor: identification of the functional ligand-binding species. Brown CB; Pihl CE; Murray EW Cytokine; 1997 Apr; 9(4):219-25. PubMed ID: 9112329 [TBL] [Abstract][Full Text] [Related]
9. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor. Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of granulocyte-macrophage colony-stimulating factor (GM-CSF) activity by suramin and suramin analogues is correlated to interaction with the GM-CSF nucleotide-binding site. Doukas M; Chavan A; Gass C; Nickel P; Boone T; Haley B Cancer Res; 1995 Nov; 55(22):5161-3. PubMed ID: 7585565 [TBL] [Abstract][Full Text] [Related]
12. In vitro affinity maturation of human GM-CSF antibodies by targeted CDR-diversification. Steidl S; Ratsch O; Brocks B; Dürr M; Thomassen-Wolf E Mol Immunol; 2008 Nov; 46(1):135-44. PubMed ID: 18722015 [TBL] [Abstract][Full Text] [Related]
13. Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes. Suzuki H; Katayama N; Ikuta Y; Mukai K; Fujieda A; Mitani H; Araki H; Miyashita H; Hoshino N; Nishikawa H; Nishii K; Minami N; Shiku H Am J Hematol; 2004 Apr; 75(4):179-89. PubMed ID: 15054806 [TBL] [Abstract][Full Text] [Related]
14. Discovery and characterization of a novel splice variant of the GM-CSF receptor alpha subunit. Pelley JL; Nicholls CD; Beattie TL; Brown CB Exp Hematol; 2007 Oct; 35(10):1483-94. PubMed ID: 17681666 [TBL] [Abstract][Full Text] [Related]
15. Molecular structure and granulocyte/macrophage colony-stimulating factor activity. Von Feldt JM; Kieber-Emmons T; Weiner DB; Ugen KE; Williams WV DNA Cell Biol; 1992 Apr; 11(3):183-91. PubMed ID: 1373625 [TBL] [Abstract][Full Text] [Related]
16. Monoclonal anti-idiotype antibody 6G6.C4 fused to GM-CSF is capable of breaking tolerance to carcinoembryonic antigen (CEA) in CEA-transgenic mice. Schwegler C; Dorn-Beineke A; Nittka S; Stocking C; Neumaier M Cancer Res; 2005 Mar; 65(5):1925-33. PubMed ID: 15753392 [TBL] [Abstract][Full Text] [Related]
17. Binding of human GM-CSF to synthetic peptides of the alpha subunit of its receptor. Di Bartolo V; Danè A; Cassano E; Viganò S; Chiello E; Verniani D; Beffy P; Pegoraro S; Hamdan M; Rovero P; Revoltella RP J Recept Signal Transduct Res; 1996; 16(1-2):77-92. PubMed ID: 8771532 [TBL] [Abstract][Full Text] [Related]
18. Mapping of human granulocyte-macrophage-colony-stimulating-factor domains interacting with the human granulocyte-macrophage-colony-stimulating-factor-receptor alpha-subunit. Brown CB; Pihl CE; Kaushansky K Eur J Biochem; 1994 Nov; 225(3):873-80. PubMed ID: 7957224 [TBL] [Abstract][Full Text] [Related]
19. Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces the osteoblastic differentiation of the human osteosarcoma cell line SaOS-2. Postiglione L; Domenico GD; Montagnani S; Spigna GD; Salzano S; Castaldo C; Ramaglia L; Sbordone L; Rossi G Calcif Tissue Int; 2003 Jan; 72(1):85-97. PubMed ID: 12232677 [TBL] [Abstract][Full Text] [Related]
20. Endogenous GM-CSF is involved as an autocrine growth factor for human osteoblastic cells. Modrowski D; Lomri A; Marie PJ J Cell Physiol; 1997 Jan; 170(1):35-46. PubMed ID: 9012783 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]